• Profile
Close

Elevation of high-sensitivity cardiac troponin T at admission is associated with increased 3-month mortality in acute ischemic stroke patients treated with thrombolysis

Clinical Cardiology Jul 30, 2019

Sui Y, et al. - In acute ischemic stroke patients treated with intravenous tissue-type plasminogen activator, researchers assed if elevated levels of high-sensitivity cardiac troponin T (hs-cTnT) are related to worse clinical outcomes (disability and/or mortality) using multivariable logistic regression. Findings revealed a significant association of older age and stroke etiology with elevated hs-cTnT levels in multivariable regression analysis. In this study, an increased risk of 90-day mortality was reported among patients relative to the elevation of hs-cTnT at admission.

Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay